LAS VEGAS, May 21, 2020 /PRNewswire/ -- Biopharmaceutical company EUCYT announced Tammy C. Luttrell, MSPT, Ph.D., CWS, FCCWS, has been promoted to Chief Scientific Officer. Luttrell's advancement follows her initial stint as Vice President of Product Development beginning last August.
The promotion also highlights EUCYT's commitment to encouraging the need for more women to join science, technology, engineering and mathematics (STEM) careers.
"I'm truly blessed to be part of such a wonderful team here in Las Vegas. This is a fabulous opportunity for me personally and for our city and university partners," said Luttrell. "With the EUCYT proprietary technology platform, we have the opportunity to truly bring bench science to the bedside and significantly improve the quality of life for patients and, at the same time, continue to push the forefront of applied science. Biological science will pave the way for continued improvement in medicine. It will allow me to focus even more intensely on the wonderful advancements our company is making in generative medicine and health. I also hope it shows just how much of a contribution women can make in STEM careers and encourage them to seek out such roles."
More on nvtip.com
Luttrell brings more than 30 years' experience, in international regenerative medicine research, primarily in the trauma, burn and wound care space. As the Chief Scientific Officer, she will continue leading EUCYT's important development of a potential treatment for COVID-19-positive patients called COVIXO.
COVIXO is a mesenchymal stem-cell-derived therapy that harnesses the power of the immune system to augment the body's natural response to invading pathogens such as severe acute respiratory syndrome coronavirus 2, the causative agent behind COVID-19. For information visit: https://eucyt.com/wp-content/uploads/2020/03/covixo.pdf.
"This promotion shows just how important Dr. Luttrell's contributions have been to a potential treatment for COVID-19 and the EUCYT team's projects in general," said Chief Executive Officer, Travis H. Bird. "She brings three decades of wound and burn care emphasis which is a perfect complement to the regenerative medicine work we're doing to define the future of and heal patients, not just treat them."
Luttrell's extensive career includes helping revamp inner-city Las Vegas' Sunrise Hospital and Medical Center's RESTORE Wound Care Center/BRCA Burn Unit. She also is a physical therapy doctoral program adjunct faculty member at Colorado University in Denver and has owned her own consulting firm since 2000, where she handles special projects for the states of Colorado and Arkansas, including legal medical case reviews, wound center consultations and staff trainings. She also provides educational presentations and lectures domestically and internationally pertaining to wound healing and skin diseases.
More on nvtip.com
About EUCYT
EUCYT is a biopharmaceutical company focusing on precision healthcare by harnessing the power within the human body to change the way people heal. EUCYT is committed to delivering safe, effective, leading-edge, advanced biologic technology.
Inquiries should be directed to Denise Bird, Director, Marketing and Sponsorships, 833.693.8298 or [email protected]
www.eucyt.com
Related Links
Follow Us on Facebook
Follow Us on Twitter
SOURCE EUCYT
Related Links
http://www.eucyt.com
The promotion also highlights EUCYT's commitment to encouraging the need for more women to join science, technology, engineering and mathematics (STEM) careers.
"I'm truly blessed to be part of such a wonderful team here in Las Vegas. This is a fabulous opportunity for me personally and for our city and university partners," said Luttrell. "With the EUCYT proprietary technology platform, we have the opportunity to truly bring bench science to the bedside and significantly improve the quality of life for patients and, at the same time, continue to push the forefront of applied science. Biological science will pave the way for continued improvement in medicine. It will allow me to focus even more intensely on the wonderful advancements our company is making in generative medicine and health. I also hope it shows just how much of a contribution women can make in STEM careers and encourage them to seek out such roles."
More on nvtip.com
- Evolve IP Offers Rapid Deployment of Desktop as a Service to Ingram Micro Partners
- Team Acme Redesigns City Of Henderson's Vinyl Wraps On Patrol Vehicles
- 626 acquires the assets of Innovatus CR and DR Business. The World Slows Down. We Move Faster
- R+M Development Closes on Refinance of Student Housing Project Amidst Pandemic
- Teenage mariachi ensemble records album during pandemic, keeping social distancing guidelines
Luttrell brings more than 30 years' experience, in international regenerative medicine research, primarily in the trauma, burn and wound care space. As the Chief Scientific Officer, she will continue leading EUCYT's important development of a potential treatment for COVID-19-positive patients called COVIXO.
COVIXO is a mesenchymal stem-cell-derived therapy that harnesses the power of the immune system to augment the body's natural response to invading pathogens such as severe acute respiratory syndrome coronavirus 2, the causative agent behind COVID-19. For information visit: https://eucyt.com/wp-content/uploads/2020/03/covixo.pdf.
"This promotion shows just how important Dr. Luttrell's contributions have been to a potential treatment for COVID-19 and the EUCYT team's projects in general," said Chief Executive Officer, Travis H. Bird. "She brings three decades of wound and burn care emphasis which is a perfect complement to the regenerative medicine work we're doing to define the future of and heal patients, not just treat them."
Luttrell's extensive career includes helping revamp inner-city Las Vegas' Sunrise Hospital and Medical Center's RESTORE Wound Care Center/BRCA Burn Unit. She also is a physical therapy doctoral program adjunct faculty member at Colorado University in Denver and has owned her own consulting firm since 2000, where she handles special projects for the states of Colorado and Arkansas, including legal medical case reviews, wound center consultations and staff trainings. She also provides educational presentations and lectures domestically and internationally pertaining to wound healing and skin diseases.
More on nvtip.com
- Getman Takes his Popular Book Fairs into the Virtual World Transforming the Way Buyers Meet Sellers of Rare Books, Maps, Prints and Ephemera
- Teleroute, Part of Alpega Group, launches an API Interface and a new Mobile App to help their growing number of customers work even more efficiently
- Space Cadet Launches A Flower Sniffer's Book Of Paper Craft to Ward off Boredom Better Than Binging TV
- Launching OneQuantum LLC the Quantum Tech startup community
- OrPro Therapeutics Advances a New Inhalation Treatment Approach for COVID-19
About EUCYT
EUCYT is a biopharmaceutical company focusing on precision healthcare by harnessing the power within the human body to change the way people heal. EUCYT is committed to delivering safe, effective, leading-edge, advanced biologic technology.
Inquiries should be directed to Denise Bird, Director, Marketing and Sponsorships, 833.693.8298 or [email protected]
www.eucyt.com
Related Links
Follow Us on Facebook
Follow Us on Twitter
SOURCE EUCYT
Related Links
http://www.eucyt.com
Filed Under: Business
0 Comments
Latest on nvtip.com
- Lantek launches version 2020 with focus on remote working and process efficiency
- Palomar Display Products, Inc. awarded a $3.5M order for gunner displays
- Jet Medical Tourism® Cites Report Saying Bariatric Surgery Works, But Millions of Eligible Patients in The Heaviest American States Cannot Get It
- Walzik Announces Automated Interface Between Dynamics GP and Strategic Movements
- NS4ed Partners with New Mexico to Maximize the Perkins V's Comprehensive Local Needs Assessment (CLNA)
- Over 400 CEOs Have Benefited from CEO Coaching International's Free Coaching Call Offer
- Certified Nutraceuticals , Inc is proud to partner with Princeton Consumer Research for a Randomized, Single-Blinded, Placebo-Controlled Study
- All Premium CBD Enters the Pain Relief Arena with CBDMEDIC Partnership
- Nutraceuticals & Agriceuticals Technology Company, Inc. Files For Patent Protection For Latest Invention Persimonal™ Persimmon Leaf Exctract- Powder
- World Humanity Commission Awards Certificate of Appreciation to Kalgidhar Society Baru Sahib for promoting Lessons of Humanity
- edjuster Celebrates Twenty Years of Excellence in Contents Claims Management for Insurers, Adjusters and Policyholders
- Gold City Music announces a NEW CD RELEASE By Former Isley Brother CHRIS JASPER..."For the Love of You"
- Braeden Lichti: The Complicated World of Biotech Investments in the Era of COVID-19
- Capgemini UK Plc Breaches GDPR Regulations
- Practicing mindfulness without addressing self-destructive habits is like placing a band-aid on a festering wound
- Glass Mosaic Artist Allison Eden Studios Pivots Into Fashion With Face Mask Line
- PODS® Las Vegas Gives Back to Organizations Working on Frontlines
- What You Need to Know About Obamacare Health Insurance
- Conscious Activation International: Learning How to Shift Your Thinking is the Best Way to Protect Your Mental Health During This Pandemic
- Restech is proud to announce the launch of PepsinCheck, a PEPTEST product branded for the U.S. consumer market